HealthStream, Inc. (NASDAQ:HSTM – Get Free Report) Director Deborah Tate sold 3,281 shares of the stock in a transaction dated Thursday, November 5th. The stock was sold at an average price of $32.19, for a total value of $105,615.39. Following the completion of the sale, the director directly owned 21,418 shares of the company’s stock, valued at approximately $689,445.42. This represents a 13.28% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.
HealthStream Price Performance
HSTM traded down $0.71 on Friday, reaching $28.89. 249,732 shares of the company traded hands, compared to its average volume of 254,352. HealthStream, Inc. has a 52-week low of $19.50 and a 52-week high of $35.60. The company has a market cap of $844.02 million, a price-to-earnings ratio of 41.27, a PEG ratio of 3.76 and a beta of 0.45. The stock’s 50 day moving average price is $31.20 and its 200-day moving average price is $25.79.
HealthStream (NASDAQ:HSTM – Get Free Report) last issued its earnings results on Monday, November 2nd. The technology company reported $0.18 EPS for the quarter, beating analysts’ consensus estimates of $0.16 by $0.02. The firm had revenue of $83.31 million for the quarter, compared to the consensus estimate of $82.24 million. HealthStream had a return on equity of 6.37% and a net margin of 6.25%. As a group, equities research analysts forecast that HealthStream, Inc. will post 0.72 earnings per share for the current fiscal year.
HealthStream Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, November 27th. Shareholders of record on Monday, November 16th will be issued a dividend of $0.0350 per share. This represents a $0.14 annualized dividend and a yield of 0.5%. The ex-dividend date is Monday, November 16th. HealthStream’s dividend payout ratio (DPR) is 20.00%.
Wall Street Analysts Forecast Growth
HSTM has been the subject of a number of recent analyst reports. Weiss Ratings upgraded shares of HealthStream from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, October 8th. Freedom Capital upgraded HealthStream to a “hold” rating in a research report on Tuesday, October 13th. Citigroup reissued a “market perform” rating on shares of HealthStream in a report on Tuesday, October 27th. Canaccord Genuity Group upped their target price on shares of HealthStream from $29.00 to $32.00 and gave the stock a “hold” rating in a research report on Wednesday. Finally, Wall Street Zen raised shares of HealthStream from a “hold” rating to a “buy” rating in a research note on Saturday, October 31st. One research analyst has rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, HealthStream currently has a consensus rating of “Hold” and an average price target of $36.00.
View Our Latest Research Report on HSTM
Institutional Investors Weigh In On HealthStream
Hedge funds and other institutional investors have recently bought and sold shares of the company. Russell Investments Group Ltd. grew its position in HealthStream by 12.0% in the third quarter. Russell Investments Group Ltd. now owns 92,038 shares of the technology company’s stock valued at $2,736,000 after purchasing an additional 9,882 shares in the last quarter. Illinois Municipal Retirement Fund grew its stake in HealthStream by 3.7% in the 3rd quarter. Illinois Municipal Retirement Fund now owns 11,755 shares of the technology company’s stock valued at $349,000 after buying an additional 423 shares during the last quarter. Bridge City Capital LLC grew its holdings in HealthStream by 17.6% in the 3rd quarter. Bridge City Capital LLC now owns 60,860 shares of the technology company’s stock valued at $1,808,000 after buying an additional 9,095 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. bought a new position in HealthStream during the third quarter worth about $160,000. Finally, Vise Technologies Inc. grew its position in HealthStream by 35.4% during the third quarter. Vise Technologies Inc. now owns 14,043 shares of the technology company’s stock worth $417,000 after buying an additional 3,671 shares in the last quarter. Institutional investors and hedge funds own 69.58% of the company’s stock.
HealthStream Company Profile
HealthStream, Inc provides workforce and provider solutions designed for healthcare organizations. Its software and services help hospitals, health systems, medical practices and other healthcare providers manage employee education, training, credentialing, compliance and professional development.
The company’s offerings include learning management and education tools, competency and performance-management solutions, and systems for managing provider credentials, privileging and enrollment.
See Also
- Five stocks we like better than HealthStream
- Q3 Earnings Have Investors Wondering: Is Mercado Libre Finally a Buy?
- CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?
- Array and Shoals Are Merging: Who Really Wins the All-Stock Solar Deal?
- Duolingo’s User Growth Is Outpacing Bookings, But Is Its Strategy Paying Off?
Receive News & Ratings for HealthStream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream and related companies with MarketBeat.com's FREE daily email newsletter.
